Active	Status	Sponsor type	Region	Phase	Filter
3 Active 33 Inactive 36 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rasmussen, Scott
CMS121, NCT05318040: Safety, Tolerability and Pharmacokinetics of , a Drug Candidate for Alzheimer's Disease, in Healthy Subjects	Completed	1	99	US	CMS121, Placebo	Virogenics, Inc., National Institute on Aging (NIA), Celerion	Alzheimer Disease	12/22	12/22
NCT05332834: A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects	Recruiting	1	78	US	SM17, Placebo	SinoMab BioScience Ltd	1. Asthma	09/23	10/23
NCT06087978: Study of RPT193 in Healthy Adult Male Subjects	Completed	1	7	US	14C RPT193	RAPT Therapeutics, Inc.	Healthy Male Subjects	10/23	10/23
Kissling, C James
No trials found
Olson, William
No trials found
Kisicki, James C
No trials found
Marion, Alan S
No trials found
Kissling, James
No trials found
Anderson, Christen
No trials found